Poehling Capital Management, Inc. Pfizer Inc Transaction History

Poehling Capital Management, Inc.

$366 Million
Q2 2024

A detailed history of Poehling Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 59,339 shares of PFE stock, worth $1.69 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

59,339

Previous 54,416 9.05%

Holding current value

$1.69 Million

Previous $1.51 Million 9.93%

% of portfolio

0.45%

Previous 0.41%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $124,354 - $145,720	4,923 Added 9.05%	59,339 $1.66 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $119,327 - $137,025	4,609 Added 9.25%	54,416 $1.51 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $275,305 - $357,591	-10,536 Reduced 17.46%	49,807 $1.43 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $537,154 - $627,879	-16,739 Reduced 21.72%	60,343 $2 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $545,303 - $630,903	15,097 Added 24.36%	77,082 $2.83 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $419,030 - $545,516	10,638 Added 20.72%	61,985 $2.53 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $60,412 - $78,861	-1,447 Reduced 2.74%	51,347 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $159,855 - $195,143	3,653 Added 7.43%	52,794 $2.31 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $46,623 - $55,280	1,002 Added 2.08%	49,141 $2.58 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $284,199 - $352,158	6,212 Added 14.82%	48,139 $2.49 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $1.51 Million - $2.24 Million	-36,604 Reduced 46.61%	41,927 $2.48 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $111,391 - $143,091	-2,838 Reduced 3.49%	78,531 $3.38 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $18,996 - $21,519	529 Added 0.65%	81,369 $3.19 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $91,963 - $103,716	2,746 Added 3.52%	80,840 $2.93 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $108,643 - $138,149	3,246 Added 4.34%	78,094 $2.88 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $23,463 - $27,527	-739 Reduced 0.98%	74,848 $2.75 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $303,218 - $367,848	10,067 Added 15.36%	75,587 $2.47 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $1.63 Million - $2.32 Million	60,151 Added 1120.34%	65,520 $2.14 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $176,747 - $200,585	5,369 New	5,369 $210,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $74,593 - $90,476	-2,164 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $6,464 - $6,891	-196 Reduced 8.31%	2,164 $79,000
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $31 - $37	1 Added 0.04%	2,360 $84,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $78,460 - $83,249	2,359	2,359 $85,000

Others Institutions Holding PFE

# of Institutions

3,231

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.

Account

Poehling Capital Management, Inc. Pfizer Inc Transaction History